Commentary on Endoscopic Chemocauterization with Trichloroacetic Acid for Congenital or Recurrent Tracheoesophageal Fistula in Children with Esophageal Atresia: Experience from a Tertiary Center

jpedsurg.org

The Stockholm group reports their stimulating retrospective experience on the controversial topic of tracheoesophageal fistula (TEF), either congenital or recurrent. Surgery, generally considered the gold standard treatment, is burdened by possible severe sequelae and recurrences. Conversely endoscopic treatment, generally limited to recurrent TEFs, is scarcely reported with variable outcomes.

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Dec 2023 · 1 min read

In brief

This commentary examines endoscopic chemocauterization using trichloroacetic acid as a minimally invasive alternative to surgical re-intervention for managing congenital and recurrent tracheoesophageal fistulas in children with esophageal atresia. The approach addresses the challenge of surgical complications and recurrence rates in this patient population.

Endoscopic chemocauterization with trichloroacetic acid offers a minimally invasive alternative for TEF management in esophageal atresia patients.
Surgical repair of TEF, while gold standard, carries risk of severe complications and recurrence even after definitive treatment.
Endoscopic approaches are traditionally reserved for recurrent TEF cases, with limited published evidence on efficacy and outcomes.
The Stockholm series adds to sparse literature on chemical ablation techniques for both congenital and recurrent tracheoesophageal fistulas.

Written by the GCMD Library team from the article.

Read it at the source ↗